Clinical Trials Browser

Withdrawn × Epstein-Barr Virus Infections × Clear all

NCT06429800 2025-04-24

A Study to Evaluate the Safety and Preliminary Efficacy of ATA3219 in Participants With Systemic Lupus Erythematosus

Lupus Erythematosus, Systemic, Lupus Nephritis, Epstein-Barr Virus Infections

NCT04183738 2020-11-10

i2-D²EFT

Acquired Immunodeficiency Syndrome, Cytomegalovirus Infections, Inflammation, Opportunistic Infections, Epstein-Barr Virus Infections, Coinfection

NCT02229981 2017-12-07

ABC-102

Phase 1/2 Withdrawn

LymphoidSarcoma

Acquired Immunodeficiency Syndrome, Lymphoma, Lymphoma, Non-Hodgkin, Sarcoma, Kaposi, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Epstein-Barr Virus Infections

NCT01704742 2016-11-08

Prospective Study of Lymphoproliferative Diseases

Withdrawn

Lymphoid

Acquired Immunodeficiency Syndrome, Hodgkin Disease, Lymphoma, Non-Hodgkin, Epstein-Barr Virus Infections